Timothy Devos
Overview
Explore the profile of Timothy Devos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
874
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Beauverd Y, Ianotto J, Thaw K, Sobas M, Sadjadian P, Curto-Garcia N, et al.
Leukemia
. 2025 Mar;
PMID: 40074852
Essential thrombocythemia (ET) and polycythemia vera (PV) are rare in adolescent and young adult (AYA). These conditions, similar to those in older patients, are linked with thrombotic complications and the...
2.
Van den Eynde R, Vrancken A, Foubert R, Tuand K, Vandendriessche T, Schrijvers A, et al.
Transfusion
. 2024 Dec;
65(2):397-409.
PMID: 39726297
Objectives: Identifying cardiac surgical patients at risk of requiring red blood cell (RBC) transfusion is crucial for optimizing their outcome. We critically appraised prognostic models preoperatively predicting perioperative exposure to...
3.
Gupta V, Oh S, Devos T, Dubruille V, Catalano J, Somervaille T, et al.
Leuk Lymphoma
. 2024 Mar;
65(7):965-977.
PMID: 38501751
A key hallmark of myelofibrosis is anemia, which ranges from mild to severe based on hemoglobin levels. To more clearly define outcomes with the Janus kinase (JAK) 1/JAK2/activin A receptor...
4.
Vermeersch G, Proost P, Struyf S, Gouwy M, Devos T
Haematologica
. 2024 Mar;
109(7):2060-2072.
PMID: 38426279
BCR::ABL1 negative myeloproliferative neoplasms (MPN) form a distinct group of hematologic malignancies characterized by sustained proliferation of cells from multiple myeloid lineages. With a median survival of 16-35 months in...
5.
Oh S, Verstovsek S, Gupta V, Platzbecker U, Devos T, Kiladjian J, et al.
EJHaem
. 2024 Feb;
5(1):105-116.
PMID: 38406514
Bone marrow fibrosis (BMF) is a pathological feature of myelofibrosis, with higher grades associated with poor prognosis. Limited data exist on the association between outcomes and BMF changes. We present...
6.
Vermeersch G, Devos T, Devos H, Lambert F, Poppe B, Van Hecke S
EJHaem
. 2023 Nov;
4(4):1143-1147.
PMID: 38024597
Erythrocytosis or polycythemia refers to a true or apparent increase in hemoglobin or hematocrit. When no etiology of erythrocytosis is identified, people are diagnosed with "idiopathic erythrocytosis" (IE). The identification...
7.
Theocharides A, Gisslinger H, De Stefano V, Accurso V, Iurlo A, Devos T, et al.
Eur J Haematol
. 2023 Oct;
112(3):379-391.
PMID: 37899734
Background: Hydroxyurea (HU) is a commonly used first-line treatment in patients with polycythemia vera (PV). However, approximately 15%-24% of PV patients report intolerance and resistance to HU. Methods: This phase...
8.
Thijssen M, Devos T, Meyfroidt G, Van Ranst M, Pourkarim M
IJID Reg
. 2023 Oct;
9:49-54.
PMID: 37868342
Objectives: Anelloviruses have been linked with host-immunocompetence and inflammation. Here, we studied the anellovirus load in hospitalized COVID-19 patients. Methods: We collected samples of patients recruited in the DAWN-Plasma trial...
9.
Schrezenmeier H, Kulasekararaj A, Mitchell L, Peffault de Latour R, Devos T, Okamoto S, et al.
Ann Hematol
. 2023 Oct;
103(1):5-15.
PMID: 37804344
Paroxysmal nocturnal hemoglobinuria (PNH) is characterized by uncontrolled terminal complement activation leading to intravascular hemolysis (IVH), thrombosis, and impairments in quality of life (QoL). The aim of this study was...
10.
Hochsmann B, Peffault de Latour R, Hill A, Roth A, Devos T, Patriquin C, et al.
Ann Hematol
. 2023 Sep;
102(11):2979-2988.
PMID: 37668788
The objective of this analysis was to identify risk factors for thromboembolic events (TE) in patients with paroxysmal nocturnal hemoglobinuria (PNH) who were not treated with C5 inhibitors. Patients with...